Pureed Fruit Pouches to Undergo Further Investigation by FDA
By Physician’s Briefing Staff HealthDay Reporter
MONDAY, Nov. 6, 2023 -- Amid reports of more illnesses and additional product recalls, U.S. health officials have expanded their investigation into potentially lead-tainted pouches of apple cinnamon pureed fruit.
The U.S. Food and Drug Administration said in an updated alert posted Friday that it has received reports of seven illnesses in at least five states possibly linked to contaminated puree.
Two new companies, Schnucks Markets of St. Louis and Weis Markets of Sunbury, Pennsylvania, announced recalls of certain cinnamon applesauce products because they may contain high levels of lead. WanaBana of Coral Gables, Florida, had previously recalled all lots and expiration dates of its apple cinnamon fruit puree.
Eating the contaminated products could result in "acute toxicity," FDA officials said. Parents and caregivers should not buy or serve the cinnamon applesauce products, which are sold through multiple retailers, including Amazon, Dollar Tree, Weis Markets, Schnucks, and Eatwell Markets.
Children and others who have consumed the products should be tested for possible lead poisoning, the agency said.
Just last week, the FDA issued an initial warning after four children in North Carolina were found to have high levels of lead in their blood that was linked to the WanaBana products, the FDA said. State health officials detected "extremely high" concentrations of lead in the pouches after analyzing multiple lots.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-07 11:07
Read more
- Virtual Yoga Classes Aid Chronic Low Back Pain
- Science Reveals Why Cancer Immunotherapies Can Sometimes Harm the Heart
- Nearly 260 Million Americans Could Be Overweight or Obese by 2050
- Young Adults Born Preterm Face Economic and Educational Challenges
- Nitrofurantoin, Cranberry Products May Cut UTI Episodes in Children
- Clinical Practice Guidelines Updated for Primary Prevention of Stroke
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions